Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025
08:00am, Wednesday, 13'th Aug 2025
ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key U.S. paten
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
08:00am, Tuesday, 12'th Aug 2025
U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett's esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart ™
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025
08:00am, Monday, 11'th Aug 2025
UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
08:00am, Tuesday, 29'th Jul 2025
Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and H
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
08:00am, Wednesday, 23'rd Jul 2025
Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company"
UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today anno
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
07:30am, Thursday, 26'th Jun 2025
UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today annou
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer
07:30am, Tuesday, 17'th Jun 2025
BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC
03:36am, Wednesday, 11'th Jun 2025
Squarepoint Ops LLC bought a new stake in shares of ProPhase Labs, Inc. (NASDAQ:PRPH – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. Th
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today annou
ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript
07:25pm, Tuesday, 20'th May 2025
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q1 2025 Earnings Conference Call May 20, 2025 10:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications Ted
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
08:00am, Tuesday, 20'th May 2025
Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has be
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025
08:00am, Tuesday, 13'th May 2025
GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, announced
ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript
09:08pm, Monday, 31'st Mar 2025
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q4 2024 Earnings Conference Call March 31, 2025 11:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications T
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
08:00am, Monday, 31'st Mar 2025
Company to Accelerate BE-Smart Commercialization as a Cash-Pay Diagnostic Significantly reduces overhead, improves margins heading into Q2 2025 Company to hold a conference call Monday, March 31, 2025
